STEPHANIE KOWALSKI: Open Payments
NPI 1346566817 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,043 in 111 payments from 19 companies in 2025. Trend: 2023 $842 · 2024 $2,040 · 2025 $2,043
Food & beverage: $2,043
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 27 | $316 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 26 | $297 |
| ABBVIE INC. | 9 | $218 |
| JAZZ PHARMACEUTICALS INC. | 7 | $188 |
| Lundbeck LLC | 6 | $118 |
| Abbott Laboratories | 1 | $118 |
| Neurocrine BioSciences, Inc. | 5 | $115 |
| Averitas Pharma Inc. | 5 | $114 |
| UCB, Inc. | 4 | $106 |
| SK Life Science, Inc. | 4 | $93 |
Products named: RELISTOR, Belbuca, BOTOX, ETERNA, INGREZZA, QUTENZA, XTAMPZA, XYWAV.
Industry payments across NY — which companies pay providers there.
